526301
MEDINOV
Invest Now
Start SIP in
MEDINOV
Performance
- Low
- ₹41
- High
- ₹41
- 52 Week Low
- ₹32
- 52 Week High
- ₹47
- Open Price₹41
- Previous Close₹41
- Volume1,225
Investment Returns
- Over 1 Month + 5.32%
- Over 3 Month + 4.94%
- Over 6 Month + 0.52%
- Over 1 Year + 13.22%
Smart Investing Starts Here Start SIP with Medinova Diagnostic Services for Steady Growth!
Medinova Diagnostic Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.4
- PEG Ratio
- -4.2
- Market Cap Cr
- 41
- P/B Ratio
- -18.6
- Average True Range
- 1.12
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.36
- RSI
- 55.95
- MFI
- 79.71
Medinova Diagnostic Services Financials
Medinova Diagnostic Services Technicals
EMA & SMA
Current Price
₹40.60
-0.41
(-1%)

-
- Bearish Moving Average 2
-
- Bullish Moving Average 14
- 20 Day
- ₹40.14
- 50 Day
- ₹39.65
- 100 Day
- ₹39.25
- 200 Day
- ₹38.65
Resistance and Support
40.81
- R3 41.63
- R2 41.41
- R1 41.03
- S1 40.43
- S2 40.21
- S3 39.83
Medinova Diagnostic Services Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-03 | Audited Results | |
2025-01-30 | Quarterly Results | |
2024-10-29 | Quarterly Results | |
2024-07-30 | Quarterly Results | |
2024-04-26 | Audited Results |
Medinova Diagnostic Services F&O
About Medinova Diagnostic Services
- NSE Symbol
- MEDINOV
- BSE Symbol
- 526301
- Managing Director
- Mr. Sunil Chandra Kondapally
- ISIN
- INE047C01019
Similar Stocks to Medinova Diagnostic Services
Medinova Diagnostic Services FAQs
Medinova Diagnostic Services share price is ₹40 As on 17 July, 2025 | 05:44
The Market Cap of Medinova Diagnostic Services is ₹40.5 Cr As on 17 July, 2025 | 05:44
The P/E ratio of Medinova Diagnostic Services is 21.4 As on 17 July, 2025 | 05:44
The PB ratio of Medinova Diagnostic Services is -18.6 As on 17 July, 2025 | 05:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.